Cargando…
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Cancer has been considered, for a long time, a genetic disease where mutations in key regulatory genes drive tumor initiation, growth, metastasis, and drug resistance. Instead, the advent of high-throughput technologies has revolutionized cancer research, allowing to investigate molecular alteration...
Autores principales: | Crispo, Fabiana, Condelli, Valentina, Lepore, Silvia, Notarangelo, Tiziana, Sgambato, Alessandro, Esposito, Franca, Maddalena, Francesca, Landriscina, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721562/ https://www.ncbi.nlm.nih.gov/pubmed/31366176 http://dx.doi.org/10.3390/cells8080798 |
Ejemplares similares
-
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
por: Crispo, Fabiana, et al.
Publicado: (2020) -
TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation
por: Lettini, Giacomo, et al.
Publicado: (2020) -
HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy
por: Condelli, Valentina, et al.
Publicado: (2019) -
BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives
por: Crispo, Fabiana, et al.
Publicado: (2019) -
Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance
por: Sisinni, Lorenza, et al.
Publicado: (2019)